JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 30 January 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02296-07v1
82/7/3381    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delboy, M. G.
Right arrow Articles by Nicola, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delboy, M. G.
Right arrow Articles by Nicola, A. V.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02296-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Cellular Proteasome Activity Facilitates Herpes Simplex Virus Entry at a Post-Penetration Step

Mark G. Delboy, Devin G. Roller, and Anthony V. Nicola*

Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, 23298-0678

* To whom correspondence should be addressed. Email: anicola{at}vcu.edu.


   Abstract

Herpes simplex virus (HSV) entry into cells is a multi-step process that engages the host cell machinery. The proteasome is a large, ATP-dependent, multi-subunit protease that plays a critical role in the maintenance of cell homeostasis. A battery of assays were used to demonstrate that proteasome inhibitors blocked an early step in HSV entry that occurred following capsid penetration into the cytosol but prior to capsid arrival at the nuclear periphery. Proteasome-dependent viral entry was not reliant on host or viral protein synthesis. MG132, a peptide aldehyde that competitively inhibits the degradative activity of the proteasome, had a reversible inhibitory effect on HSV entry. HSV can use endocytic or non-endocytic pathways to enter cells. These distinct entry routes were both dependent on proteasome-mediated proteolysis. In addition, HSV successfully entered cells in the absence of a functional host ubiquitin-activating enzyme, suggesting that viral entry is ubiquitin-independent. We propose that proteasomal degradation of virion and/or host proteins is required for efficient delivery of incoming HSV capsids to the nucleus.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.